220 related articles for article (PubMed ID: 15148767)
1. [Chronological changes of incidence rates, clinical stages and pathological differentiation of prostate cancer in Gunma Prefecture, Japan].
Nakata S; Ohtake N; Kubota Y; Ito K; Suzuki K; Yamanaka H;
Hinyokika Kiyo; 2004 Mar; 50(3):165-70. PubMed ID: 15148767
[TBL] [Abstract][Full Text] [Related]
2. Changes in baseline PSA levels in Japanese men from 1988 to 2003.
Ohi M; Ito K; Yamamoto T; Miyakubo M; Takechi H; Kubota Y; Suzuki K
Urology; 2008 Jul; 72(1):95-8. PubMed ID: 18455775
[TBL] [Abstract][Full Text] [Related]
3. [Statistical analysis of the prostatic cancer patients detected from 1985 to 1989 in and around Gunma prefecture].
Nakata S; Imai K; Uchida T; Yamanaka H; Hashimoto K; Ogura H; Nakano K; Kurita M; Saito Y; Ono Y
Hinyokika Kiyo; 1991 Oct; 37(10):1261-9; discussion 1269-70. PubMed ID: 1755419
[TBL] [Abstract][Full Text] [Related]
4. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
[TBL] [Abstract][Full Text] [Related]
5. [Prostate tumor and its diagnosis].
Yamanaka H
Rinsho Byori; 2001 Jul; 49(7):633-7. PubMed ID: 11519121
[TBL] [Abstract][Full Text] [Related]
6. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening.
Gilliland F; Becker TM; Smith A; Key CR; Samet JM
Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):105-11. PubMed ID: 8049631
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan.
Takechi H; Ito K; Yamamoto T; Miyakubo M; Ohi M; Suzuki K
Urology; 2008 Nov; 72(5):1111-5. PubMed ID: 18342926
[TBL] [Abstract][Full Text] [Related]
8. Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era.
Tonita JM; Skarsgard D; Muhajarine N
Cancer Causes Control; 2009 Mar; 20(2):201-9. PubMed ID: 18825504
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiological trends in prostate cancer over the last years].
Luján Galán M; Páez Borda A; Chiva Robles V; Santonja Garriga C; Romero Cajigal I; Berenguer Sánchez A
Arch Esp Urol; 2004 Oct; 57(8):817-25. PubMed ID: 15560270
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of prostate cancer in Japanese men in the eras before and after serum prostate-specific antigen testing.
Okihara K; Nakanishi H; Nakamura T; Mizutani Y; Kawauchi A; Miki T
Int J Urol; 2005 Jul; 12(7):662-7. PubMed ID: 16045559
[TBL] [Abstract][Full Text] [Related]
12. The increased rate of prostate specific antigen testing has not affected prostate cancer presentation in an inner city population in the UK.
Mokete M; Shackley DC; Betts CD; O'Flynn KJ; Clarke NW
BJU Int; 2006 Feb; 97(2):266-9. PubMed ID: 16430626
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of prostate cancer in Gunma prefecture.
Kurokawa K; Fukabori Y; Ito K; Suzuki K; Nakata S; Suzuki T; Imai K; Namiki TS; Yamanaka H
Int J Androl; 2000; 23 Suppl 2():40-2. PubMed ID: 10849492
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological characteristics of prostate cancer in Gunma Prefecture, Japan. Gunma University Urological Oncology Study Group.
Nakata S; Sato J; Imai K; Yamanaka H; Ichinose Y
Int J Urol; 1995 Jul; 2(3):191-7. PubMed ID: 8536137
[TBL] [Abstract][Full Text] [Related]
15. [Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990].
Grosclaude P; Menegoz F; Schaffer P; Macé Lesec'h J; Arveux P; Le Mab G; Soulié M; Villers A
Prog Urol; 1997 Sep; 7(4):647-54. PubMed ID: 9410328
[TBL] [Abstract][Full Text] [Related]
16. [Observational survey on variations of prostate cancer incidence by stage in the Nord-Pas-de-Calais region between 1998 and 2004].
Flamand V; Zini L; Salleron J; Fantoni JC; Biserte J; Villers A
Prog Urol; 2008 Jan; 18(1):53-9. PubMed ID: 18342157
[TBL] [Abstract][Full Text] [Related]
17. Changing demography of prostate cancer in Asia.
Sim HG; Cheng CW
Eur J Cancer; 2005 Apr; 41(6):834-45. PubMed ID: 15808953
[TBL] [Abstract][Full Text] [Related]
18. Is cancer of the prostate rare in tropical (black) Africa? Case series from the Centre Hospitalier et Universitaire and the Hospital General de Yaounde from 1986 to 1990.
Angwafo FF; Yomi J; Mbakop A
Bull Cancer Radiother; 1994; 81(2):155-9. PubMed ID: 7702897
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of prostate cancer in the mediterranean population of Croatia--a thirty-three year retrospective study.
Spanjol J; Maricić A; Cicvarić T; Valencić M; Oguić R; Tadin T; Fuckar D; Bobinac M
Coll Antropol; 2007 Mar; 31(1):235-9. PubMed ID: 17598407
[TBL] [Abstract][Full Text] [Related]
20. The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival.
Varenhorst E; Garmo H; Holmberg L; Adolfsson J; Damber JE; Hellström M; Hugosson J; Lundgren R; Stattin P; Törnblom M; Johansson JE
Scand J Urol Nephrol; 2005; 39(2):117-23. PubMed ID: 16019764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
